Syed Samar Raza, MD
Internal Medicine · Bay Shore, NYNPI 1285734715
Payments from drug & device makers
Across 111 payments — averaging $406.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$45K
- Acadia Pharmaceuticals Inc$128
- Otsuka America Pharmaceutical, Inc.$123
- Artivion, Inc.$118
- Johnson & Johnson$66
- Atricure, Inc.$62
- plus $116 from 4 others
What the payments were for
- Consulting fees$1,2803%
- Speaking & faculty fees$37,60083%
- Travel & lodging$1,8354%
- Food & beverage$4,44410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 95 | $44,546 |
| Acadia Pharmaceuticals Inc | 6 | $128 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Artivion, Inc. | 1 | $118 |
| Johnson & Johnson | 2 | $66 |
| Atricure, Inc. | 1 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,159 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $4,564 |
| Atorvastatin Calcium | 80 | $723 |
| Metoprolol Succinate | 39 | $552 |
| Sertraline Hcl | 24 | $497 |
| Cefpodoxime Proxetil | 11 | $458 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 11 | $319 |
| Trazodone Hcl | 37 | $318 |
| Pantoprazole Sodium | 18 | $269 |
| Haloperidol | 12 | $240 |
| Baclofen | 13 | $185 |
| Metformin Hcl | 17 | $183 |
| Rosuvastatin Calcium | 14 | $176 |
| Ondansetron Hcl | 13 | $171 |
| Mirtazapine | 18 | $170 |
| Olanzapine | 12 | $160 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bay Shore
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.